These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 1827210

  • 1. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.
    Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL.
    Science; 1991 May 03; 252(5006):715-8. PubMed ID: 1827210
    [Abstract] [Full Text] [Related]

  • 2. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M, Rénia L, Motard A, Miltgen F, Pétour P, Chauhan V, Corradin G, Mazier D.
    Int Immunol; 1997 Dec 03; 9(12):1817-24. PubMed ID: 9466309
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
    Charoenvit Y, Mellouk S, Cole C, Bechara R, Leef MF, Sedegah M, Yuan LF, Robey FA, Beaudoin RL, Hoffman SL.
    J Immunol; 1991 Feb 01; 146(3):1020-5. PubMed ID: 1988490
    [Abstract] [Full Text] [Related]

  • 4. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M, Brice GT, Rogers WO, Doolan DL, Charoenvit Y, Jones TR, Majam VF, Belmonte A, Lu M, Belmonte M, Carucci DJ, Hoffman SL.
    Infect Immun; 2002 Jul 01; 70(7):3493-9. PubMed ID: 12065488
    [Abstract] [Full Text] [Related]

  • 5. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.
    Khusmith S, Sedegah M, Hoffman SL.
    Infect Immun; 1994 Jul 01; 62(7):2979-83. PubMed ID: 8005684
    [Abstract] [Full Text] [Related]

  • 6. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
    Charoenvit Y, Majam VF, Corradin G, Sacci JB, Wang R, Doolan DL, Jones TR, Abot E, Patarroyo ME, Guzman F, Hoffman SL.
    Infect Immun; 1999 Nov 01; 67(11):5604-14. PubMed ID: 10531206
    [Abstract] [Full Text] [Related]

  • 7. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL.
    J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640
    [Abstract] [Full Text] [Related]

  • 8. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.
    Wang HH, Rogers WO, Kang YH, Sedegah M, Hoffman SL.
    Mol Biochem Parasitol; 1995 Feb 01; 69(2):139-48. PubMed ID: 7770079
    [Abstract] [Full Text] [Related]

  • 9. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.
    Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero P, Maryanski JL, Nussenzweig RS, Zavala F.
    Int Immunol; 1991 Jun 01; 3(6):579-85. PubMed ID: 1716146
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
    Sedegah M, Hedstrom R, Hobart P, Hoffman SL.
    Proc Natl Acad Sci U S A; 1994 Oct 11; 91(21):9866-70. PubMed ID: 7937907
    [Abstract] [Full Text] [Related]

  • 12. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
    Wang R, Charoenvit Y, Daly TM, Long CA, Corradin G, Hoffman SL.
    Immunol Lett; 1996 Nov 11; 53(2-3):83-93. PubMed ID: 9024983
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM.
    Int Immunopharmacol; 2003 Oct 11; 3(10-11):1401-11. PubMed ID: 12946436
    [Abstract] [Full Text] [Related]

  • 15. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.
    Mauduit M, Grüner AC, Tewari R, Depinay N, Kayibanda M, Chavatte JM, Franetich JF, Crisanti A, Mazier D, Snounou G, Rénia L.
    PLoS One; 2009 Nov 05; 4(11):e7717. PubMed ID: 19890387
    [Abstract] [Full Text] [Related]

  • 16. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.
    Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghten RA, Beaudoin RL, Smith D, Hoffman SL.
    Vaccine; 1992 Nov 05; 10(9):578-84. PubMed ID: 1323900
    [Abstract] [Full Text] [Related]

  • 17. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides.
    Widmann C, Romero P, Maryanski JL, Corradin G, Valmori D.
    J Immunol Methods; 1992 Oct 19; 155(1):95-9. PubMed ID: 1383348
    [Abstract] [Full Text] [Related]

  • 18. Active and passive immunization against Plasmodium yoelii sporozoites.
    Charoenvit Y, Sedegah M, Yuan LF, Gross M, Cole C, Bechara R, Leef MF, Robey FA, Lowell GH, Beaudoin RL.
    Bull World Health Organ; 1990 Oct 19; 68 Suppl(Suppl):26-32. PubMed ID: 1709834
    [Abstract] [Full Text] [Related]

  • 19. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM, Burns JM.
    J Immunol; 2008 Jan 01; 180(1):444-53. PubMed ID: 18097046
    [Abstract] [Full Text] [Related]

  • 20. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C, Collins WE, Xiao L, Saekhou AM, Reed RC, Nelson CO, Hunter RL, Jue DL, Fang S, Wohlhueter RM, Udhayakumar V, Lal AA.
    Vaccine; 1997 Mar 01; 15(4):377-86. PubMed ID: 9141208
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.